Delivery Order SPE2DB20D3101-SPE2DB24FQSW4
- Not listed
- This is a $17,400.04 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of MAVYRET 100-40 MG TABLET 84S. The contract has an ultimate completion date of July 18, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MAVYRET 100-40 mg tablets in a quantity of 84 units, valued at $17,819.42. This competitively awarded, firm fixed-price delivery order was issued on November 18, 2025, with an ultimate completion date of November 19, 2025. The contract utilizes no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a $17,709.89 delivery order to AmerisourceBergen Drug Corp for the supply of Mavyret 100-40 mg tablets (84-count units) on November 12, 2025, with an ultimate completion date of November 13, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order valued at $7,742.98 to AmerisourceBergen Drug Corp for 84 tablets of Mavyret 100-40 mg on November 17, 2025, with completion scheduled for November 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Harvoni 90-400 mg tablets. The $76,765.38 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which allows the DLA to efficiently procure...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $96,035.53 placed by the Defense Logistics Agency (DLA). The contract covers the delivery of Vemlidy 25 mg tablets, a pharmaceutical product, to support federal healthcare programs. The award is not designated as a set-aside contract. It is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $4,598.37 to AmerisourceBergen Drug Corp for HARVONI 90-400 mg tablets (28-count unit of use) on September 15, 2025, with completion targeted for September 16, 2025. This firm fixed-price, non-set-aside contract was awarded competitively and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. HARVONI is an antiviral medication used to treat hepatitis C and represents a specialized...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $27,236.80, is for the supply of VEKLURY 100 mg vials, a critical pharmaceutical product. This order is placed under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,686.26 firm fixed-price delivery order is for the supply of the medication Vemlidy 25 mg tablet, with a completion date of November 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $67,792.74 firm-fixed-price delivery order is for the supply of Vemlidy 25 mg tablets to support military healthcare needs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen's parent company, Cencora, Inc., holds with the DLA Troop Support...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQSW4Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $19,836.92 firm fixed-price delivery order is for the supply of MAVYRET 100-40 MG TABLET 84S, a pharmaceutical product, with an ultimate completion date of October 17, 2023. The award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.8k | 10/16/23 |